Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

MTRAC Reviews - October 2013

MTRAC issued two new Commissioning Support reviews in October 2013. The reviews cover perampanel and zonisamide.

The perampanel (Fycompa®) summary advises that this drug is not suitable for prescribing in primary care for adjunctive treatment of partial seizures in epilepsy. It is recommended that prescribing should occur in a tertiary care setting and notes that patients are likely to receive continued specialist supervision.

The zonisamide (Zonegran®) summary advises that this drug is suitable for restricted prescribing under defined conditions as monotherapy for partial seizures in epilepsy. It is recommended that the treatment is initiated and stabilised by a specialist after which maintenance therapy can be issued in primary care. It is expected that patients would continue to receive follow-up in secondary care.

Action: Clinicians should be aware of these reviews and use the recommendations to guide appropriate use of these medicines in current practice.

Share 'MTRAC Reviews - October 2013' on Email Share 'MTRAC Reviews - October 2013' on Delicious Share 'MTRAC Reviews - October 2013' on Digg Share 'MTRAC Reviews - October 2013' on Facebook Share 'MTRAC Reviews - October 2013' on Google+ Share 'MTRAC Reviews - October 2013' on reddit Share 'MTRAC Reviews - October 2013' on StumbleUpon Share 'MTRAC Reviews - October 2013' on Twitter

atomic-wealth

No Comments to “MTRAC Reviews - October 2013”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,209 spam comments.

atomic-wealth
fond-illness
summer